--- title: "Calumet (NASDAQ:CLMT) Reaches New 1-Year High Following Analyst Upgrade" type: "News" locale: "en" url: "https://longbridge.com/en/news/296237577.md" description: "Calumet (NASDAQ:CLMT) shares hit a new 52-week high following Goldman Sachs' price target upgrade to $45.00, though the firm maintains a neutral rating. Other analysts hold mixed views, with TD Cowen issuing a 'hold', Citigroup a 'buy', and Weiss Ratings a 'sell'. The stock traded up to $49.38. Additionally, insider Daniel J. Sajkowski sold shares, while major institutional investors like BlackRock and Two Seas Capital increased their holdings." datetime: "2026-08-18T13:40:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296237577.md) - [en](https://longbridge.com/en/news/296237577.md) - [zh-HK](https://longbridge.com/zh-HK/news/296237577.md) generator: "portal-rs" --- # Calumet (NASDAQ:CLMT) Reaches New 1-Year High Following Analyst Upgrade Calumet, Inc. (NASDAQ:CLMT - Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday after The Goldman Sachs Group raised their price target on the stock from $40.00 to $45.00. The Goldman Sachs Group currently has a neutral rating on the stock. Calumet traded as high as $49.38 and last traded at $48.8710, with a volume of 787 shares trading hands. The stock had previously closed at $48.35. - 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments Other equities research analysts have also issued reports about the company. TD Cowen lifted their price target on Calumet from $34.00 to $40.00 and gave the company a "hold" rating in a report on Wednesday, August 12th. Weiss Ratings restated a "sell (d-)" rating on shares of Calumet in a report on Friday, August 7th. Finally, Citigroup reaffirmed a "buy" rating on shares of Calumet in a research report on Monday, August 10th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Calumet has a consensus rating of "Hold" and an average price target of $42.75. **View Our Latest Analysis on Calumet** ## Insider Buying and Selling In other Calumet news, Director Daniel J. Sajkowski sold 4,240 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total transaction of $153,318.40. Following the transaction, the director owned 77,718 shares in the company, valued at $2,810,282.88. This trade represents a 5.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 3.15% of the stock is currently owned by company insiders. ## Institutional Trading of Calumet Several large investors have recently modified their holdings of CLMT. Two Seas Capital LP bought a new position in Calumet in the 2nd quarter worth $238,442,000. Bank of America Corp DE acquired a new position in Calumet during the 2nd quarter worth $35,348,000. Renaissance Technologies LLC bought a new stake in Calumet during the first quarter valued at about $14,066,000. Mariner LLC grew its position in shares of Calumet by 959.6% in the third quarter. Mariner LLC now owns 369,408 shares of the oil and gas company's stock valued at $6,742,000 after purchasing an additional 334,544 shares during the last quarter. Finally, BlackRock Inc. increased its stake in shares of Calumet by 5.1% in the second quarter. BlackRock Inc. now owns 5,234,106 shares of the oil and gas company's stock worth $188,532,000 after purchasing an additional 253,578 shares during the period. 34.41% of the stock is owned by institutional investors. ## Calumet Trading Up 1.0% The firm has a market cap of $4.29 billion, a price-to-earnings ratio of -31.45 and a beta of 0.71. The firm has a 50-day moving average of $39.30 and a two-hundred day moving average of $33.82. Calumet (NASDAQ:CLMT - Get Free Report) last released its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($1.16). The business had revenue of $1.45 billion during the quarter, compared to analysts' expectations of $1.12 billion. The firm's revenue was up 40.8% on a year-over-year basis. During the same quarter in the prior year, the business earned ($1.70) earnings per share. As a group, equities analysts anticipate that Calumet, Inc. will post 0.46 EPS for the current year. ## About Calumet (Get Free Report) Calumet Specialty Products Partners, L.P. NASDAQ: CLMT is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements. Calumet's product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions. ## Read More - Five stocks we like better than Calumet - Orbiting Wealth: Institutions Load Up SpaceX - Uncle Sam’s Chip Trick: How the Government Built a Silicon Moat - 3 Infrastructure Stocks Built Around the Backbone of the Economy - Moonshot to Money: Intuitive Machines Lands $600M Defense Win *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in Calumet Right Now? Before you consider Calumet, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list. While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [CLMT.US](https://longbridge.com/en/quote/CLMT.US.md) - [BLK.US](https://longbridge.com/en/quote/BLK.US.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [C.US](https://longbridge.com/en/quote/C.US.md) - [BAC.US](https://longbridge.com/en/quote/BAC.US.md) - [LUNR.US](https://longbridge.com/en/quote/LUNR.US.md) - [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md) - [C-R.US](https://longbridge.com/en/quote/C-R.US.md) - [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md) - [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md) - [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md) - [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md) - [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md) - [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md) - [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md) - [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md) - [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md) - [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md) - [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md) - [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md) - [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md) - [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md) - [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md) - [8648.JP](https://longbridge.com/en/quote/8648.JP.md) - [BTX.US](https://longbridge.com/en/quote/BTX.US.md) - [BIT.RT*.US](https://longbridge.com/en/quote/BIT.RT*.US.md) - [BDJ.US](https://longbridge.com/en/quote/BDJ.US.md) - [BSTZ.US](https://longbridge.com/en/quote/BSTZ.US.md) - [BIT.RT.US](https://longbridge.com/en/quote/BIT.RT.US.md) - [LUNRW.US](https://longbridge.com/en/quote/LUNRW.US.md) ## Related News & Research - [How Investors May Respond To BlackRock (BLK) Expanding Model Portfolios Amid ETF Momentum](https://longbridge.com/en/news/298059745.md) - [REG - Smiths Group PLC - Holding(s) in Company](https://longbridge.com/en/news/297636337.md) - [Is Calumet (CLMT) Fully Priced On Balance Sheet Risks?](https://longbridge.com/en/news/297621921.md) - [Calumet targets 200 million gallons of SAF output at Montana Renewables by end-2028 with USD 137 million expansion plan](https://longbridge.com/en/news/297641273.md) - [REG - Mkango Resources Ltd - FILING OF AMENDED FORM F-4](https://longbridge.com/en/news/297899571.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**